MEDICAL BIO WARFARE DEFENSE PLAN 8 APR 91

File: 970101_sep96_decls1_0051.txt
Page: 0051
Total Pages: 194

Subject: MEDICAL BIO WARFARE DEFENSE PLAN  8 APR 91                      

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003202

Folder Title: MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN                                                   

Document Number:          2

Folder Seq  #:         25





                                               (NrrinrT
                                               I             UNCLASSIFIED
                                              UL-UIXL I



                                        to          Attack, For potential anthrax attack,
          the 'fat risk" units will be notified           tely to begin taking their
          621@
          vaccimtlcn series. Vigilanoe will be                   for other anthrax pos3.tive
          cases.

                     (2)                to Botulinum @ Attack, selective ilse of the
          antitcx-Ln @ be initiated upon decision of                authorities              to
                    policy, if patients       it definitive botulimn
                    ve care such as respirator/ support and intubaticn w3-ll be provided
          as the situat3.cn permits at medical treatment facilities.

                 c. (U)                 Samles, Sanples F       the XM2 collectors will be
          sent         tely to ACR and               foll                 attack for rapid
          analyr.is.

          2-3.   @ Bioloctical Warfare Iaboratory Identification Capabilities (996th
          Lab, NFL, AFL) (ref 4).

                 a. @ Anthrax, The ArR labs oan perform
          for artthrax. Positive test results need to be cmf@ by @ assay
                      . nW can also perform antibiotic sensitivity tests to select the
          best antibiotic for post              treatment.

                     (1) I" n*



                     (2) @ The                                                      blood or
          serum samples frm             ti-c patients to prevent quantitative information
          on the PA antigen.

                     (3)
                                                                           can be
          performed. After 3 to 4 hmm of culturirg, ark-tlysis for the PA antigen as
          an indication of the presence of anthrax in the sample can be performed.

             T==. NFL has kits for              on of       mm toxin








                 c. (U) Stamhvl@                     A SE-ACl.2.3D. Antigen detection
          test is         le.





                                                   2-5


                                               UNCLASSI
                                                cIrp.or.E?

Document 194 f:/Week-36/BX003202/MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN/medical bio warfare defense plan 8 apr 91:1224960931152
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN
Folder Seq # = 25
Subject = MEDICAL BIO WARFARE DEFENSE PLAN 8 APR 91
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 24-DEC-1996